S230: CD22 CAR T CELL THERAPY IS SAFE AND EFFECTIVE IN PATIENTS WITH LARGE B CELL LYMPHOMA WHO HAVE RELAPSED AFTER CD19 CAR T CELL THERAPY.

Detalles Bibliográficos
Autores principales: Frank, Matthew J., Baird, John, Kramer, Anne, Patel, Shabnum, Sahaf, Bita, Craig, Juliana, Crawford, Emma, Younes, Sheren, Oak, Jean, Natkunan, Yasodha, Spiegel, Jay, Ehlinger, Zachary, Chinnasamy, Harshini, Reynolds, Warren, Srinagesh, Hrishi, Su, Yi-Jiun, Egeler, Emily, Feldman, Steven, Mackall, Crystal, Muffly, Lori, Miklos, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Oral Sessions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428455/
http://dx.doi.org/10.1097/01.HS9.0000967832.33621.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428455/
http://dx.doi.org/10.1097/01.HS9.0000967832.33621.69

Ejemplares similares